开发和验证用于卫生决策者决策支持工具的婴儿 HIV 检测和筛查策略微观模拟模型的元模型。

IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES
MDM Policy and Practice Pub Date : 2020-06-12 eCollection Date: 2020-01-01 DOI:10.1177/2381468320932894
Djøra I Soeteman, Stephen C Resch, Hawre Jalal, Caitlin M Dugdale, Martina Penazzato, Milton C Weinstein, Andrew Phillips, Taige Hou, Elaine J Abrams, Lorna Dunning, Marie-Louise Newell, Pamela P Pei, Kenneth A Freedberg, Rochelle P Walensky, Andrea L Ciaranello
{"title":"开发和验证用于卫生决策者决策支持工具的婴儿 HIV 检测和筛查策略微观模拟模型的元模型。","authors":"Djøra I Soeteman, Stephen C Resch, Hawre Jalal, Caitlin M Dugdale, Martina Penazzato, Milton C Weinstein, Andrew Phillips, Taige Hou, Elaine J Abrams, Lorna Dunning, Marie-Louise Newell, Pamela P Pei, Kenneth A Freedberg, Rochelle P Walensky, Andrea L Ciaranello","doi":"10.1177/2381468320932894","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background.</b> Metamodels can simplify complex health policy models and yield instantaneous results to inform policy decisions. We investigated the predictive validity of linear regression metamodels used to support a real-time decision-making tool that compares infant HIV testing/screening strategies. <b>Methods.</b> We developed linear regression metamodels of the Cost-Effectiveness of Preventing AIDS Complications Pediatric (CEPAC-P) microsimulation model used to predict life expectancy and lifetime HIV-related costs/person of two infant HIV testing/screening programs in South Africa. Metamodel performance was assessed with cross-validation and Bland-Altman plots, showing between-method differences in predicted outcomes against their means. Predictive validity was determined by the percentage of simulations in which the metamodels accurately predicted the strategy with the greatest net health benefit (NHB) as projected by the CEPAC-P model. We introduced a zone of indifference and investigated the width needed to produce between-method agreement in 95% of the simulations. We also calculated NHB losses from \"wrong\" decisions by the metamodel. <b>Results.</b> In cross-validation, linear regression metamodels accurately approximated CEPAC-P-projected outcomes. For life expectancy, Bland-Altman plots showed good agreement between CEPAC-P and the metamodel (within 1.1 life-months difference). For costs, 95% of between-method differences were within $65/person. The metamodels predicted the same optimal strategy as the CEPAC-P model in 87.7% of simulations, increasing to 95% with a zone of indifference of 0.24 life-months ( ∼ 7 days). The losses in health benefits due to \"wrong\" choices by the metamodel were modest (range: 0.0002-1.1 life-months). <b>Conclusions.</b> For this policy question, linear regression metamodels offered sufficient predictive validity for the optimal testing strategy as compared with the CEPAC-P model. Metamodels can simulate different scenarios in real time, based on sets of input parameters that can be depicted in a widely accessible decision-support tool.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"5 1","pages":"2381468320932894"},"PeriodicalIF":1.9000,"publicationDate":"2020-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/7e/10.1177_2381468320932894.PMC7294506.pdf","citationCount":"0","resultStr":"{\"title\":\"Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.\",\"authors\":\"Djøra I Soeteman, Stephen C Resch, Hawre Jalal, Caitlin M Dugdale, Martina Penazzato, Milton C Weinstein, Andrew Phillips, Taige Hou, Elaine J Abrams, Lorna Dunning, Marie-Louise Newell, Pamela P Pei, Kenneth A Freedberg, Rochelle P Walensky, Andrea L Ciaranello\",\"doi\":\"10.1177/2381468320932894\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background.</b> Metamodels can simplify complex health policy models and yield instantaneous results to inform policy decisions. We investigated the predictive validity of linear regression metamodels used to support a real-time decision-making tool that compares infant HIV testing/screening strategies. <b>Methods.</b> We developed linear regression metamodels of the Cost-Effectiveness of Preventing AIDS Complications Pediatric (CEPAC-P) microsimulation model used to predict life expectancy and lifetime HIV-related costs/person of two infant HIV testing/screening programs in South Africa. Metamodel performance was assessed with cross-validation and Bland-Altman plots, showing between-method differences in predicted outcomes against their means. Predictive validity was determined by the percentage of simulations in which the metamodels accurately predicted the strategy with the greatest net health benefit (NHB) as projected by the CEPAC-P model. We introduced a zone of indifference and investigated the width needed to produce between-method agreement in 95% of the simulations. We also calculated NHB losses from \\\"wrong\\\" decisions by the metamodel. <b>Results.</b> In cross-validation, linear regression metamodels accurately approximated CEPAC-P-projected outcomes. For life expectancy, Bland-Altman plots showed good agreement between CEPAC-P and the metamodel (within 1.1 life-months difference). For costs, 95% of between-method differences were within $65/person. The metamodels predicted the same optimal strategy as the CEPAC-P model in 87.7% of simulations, increasing to 95% with a zone of indifference of 0.24 life-months ( ∼ 7 days). The losses in health benefits due to \\\"wrong\\\" choices by the metamodel were modest (range: 0.0002-1.1 life-months). <b>Conclusions.</b> For this policy question, linear regression metamodels offered sufficient predictive validity for the optimal testing strategy as compared with the CEPAC-P model. Metamodels can simulate different scenarios in real time, based on sets of input parameters that can be depicted in a widely accessible decision-support tool.</p>\",\"PeriodicalId\":36567,\"journal\":{\"name\":\"MDM Policy and Practice\",\"volume\":\"5 1\",\"pages\":\"2381468320932894\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2020-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/7e/10.1177_2381468320932894.PMC7294506.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MDM Policy and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/2381468320932894\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MDM Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2381468320932894","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景。元模型可以简化复杂的卫生政策模型,并产生即时结果,为政策决策提供依据。我们研究了线性回归元模型的预测有效性,该元模型用于支持一种实时决策工具,对婴儿 HIV 检测/筛查策略进行比较。方法。我们开发了预防艾滋病并发症儿科成本效益(CEPAC-P)微观模拟模型的线性回归元模型,用于预测南非两个婴儿 HIV 检测/筛查项目的预期寿命和与 HIV 相关的终生成本/人。元模型的性能是通过交叉验证和布兰-阿尔特曼图来评估的,布兰-阿尔特曼图显示了不同方法之间预测结果与平均值之间的差异。预测有效性由元模型准确预测 CEPAC-P 模型预测的净健康效益(NHB)最大的策略的模拟百分比决定。我们引入了无差异区,并研究了在 95% 的模拟中产生方法间一致性所需的宽度。我们还计算了元模型 "错误 "决策造成的 NHB 损失。结果在交叉验证中,线性回归元模型准确地逼近了 CEPAC-P 预测的结果。在预期寿命方面,Bland-Altman 图显示 CEPAC-P 和元模型之间的一致性很好(寿命月数差异在 1.1 个月以内)。在成本方面,95% 的方法间差异在 65 美元/人以内。在 87.7% 的模拟中,元模型预测了与 CEPAC-P 模型相同的最优策略,在 0.24 个生命月(∼ 7 天)的无差异区内,最优策略的预测率提高到 95%。元模型的 "错误 "选择造成的健康效益损失不大(范围:0.0002-1.1 个生命月)。结论。对于这一政策问题,与 CEPAC-P 模型相比,线性回归元模型为最佳检测策略提供了足够的预测效力。元模型可以根据输入参数集实时模拟不同的情况,这些参数集可以在广泛使用的决策支持工具中进行描述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.

Background. Metamodels can simplify complex health policy models and yield instantaneous results to inform policy decisions. We investigated the predictive validity of linear regression metamodels used to support a real-time decision-making tool that compares infant HIV testing/screening strategies. Methods. We developed linear regression metamodels of the Cost-Effectiveness of Preventing AIDS Complications Pediatric (CEPAC-P) microsimulation model used to predict life expectancy and lifetime HIV-related costs/person of two infant HIV testing/screening programs in South Africa. Metamodel performance was assessed with cross-validation and Bland-Altman plots, showing between-method differences in predicted outcomes against their means. Predictive validity was determined by the percentage of simulations in which the metamodels accurately predicted the strategy with the greatest net health benefit (NHB) as projected by the CEPAC-P model. We introduced a zone of indifference and investigated the width needed to produce between-method agreement in 95% of the simulations. We also calculated NHB losses from "wrong" decisions by the metamodel. Results. In cross-validation, linear regression metamodels accurately approximated CEPAC-P-projected outcomes. For life expectancy, Bland-Altman plots showed good agreement between CEPAC-P and the metamodel (within 1.1 life-months difference). For costs, 95% of between-method differences were within $65/person. The metamodels predicted the same optimal strategy as the CEPAC-P model in 87.7% of simulations, increasing to 95% with a zone of indifference of 0.24 life-months ( ∼ 7 days). The losses in health benefits due to "wrong" choices by the metamodel were modest (range: 0.0002-1.1 life-months). Conclusions. For this policy question, linear regression metamodels offered sufficient predictive validity for the optimal testing strategy as compared with the CEPAC-P model. Metamodels can simulate different scenarios in real time, based on sets of input parameters that can be depicted in a widely accessible decision-support tool.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MDM Policy and Practice
MDM Policy and Practice Medicine-Health Policy
CiteScore
2.50
自引率
0.00%
发文量
28
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信